Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4700-4707

  Byrd, Thomas F ^a,b   Lyons, C Rick ^b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CELL AGGREGATION; CLINICAL FEATURE; CONTROLLED STUDY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0032773728     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4700-4707.1999     Document Type: Article

References (34)

1. Armstrong, J. A., and P. D. A. Hart. 1975. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. J. Exp. Med. 142:1-16.
2. Barker, L. P., K. M. George, S. Falkow, and P. L. Small. 1997. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect. Immun. 65:1497-1504.
3. Beaman, B. Personal communication.
4. Behling, C. A., B. Bennett, K. Takayama, and R. L. Hunter. 1993. Development of a trehalose 6,6́-dimycolate model which explains cord formation by Mycobacterium tuberculosis. Infect. Immun. 61:2296-2303.
5. Belisle, J. T., M. R. McNeil, D. Chatterjee, J. M. Inamine, and P. J. Brennan. 1993. Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium. J. Biol. Chem. 268: 10510-10516.
6. Belisle, J. T., and P. J. Brennan. 1989. Chemical basis of rough and smooth variation in mycobacteria. J. Bacteriol. 171:3465-3470.
7. Belisle, J. T., L. Pascopella, J. M. Inamine, P. J. Brennan, and W. R. Jacobs. 1991. Isolation and expression of a gene cluster responsible for the biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium. J. Bacteriol. 173:6991-6997.
8. Belisle, J. T., K. Klaczkiewicz, P. J. Brennan, W. R. Jacobs, Jr., and J. M. Inamine. 1993. Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptido-lipid expression. J. Biol. Chem. 268:10517-10523.
9. Brennan, P. J., and P. Draper. 1994. Ultrastructure of Mycobacterium tuberculosis, p. 274-277. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
10. Byrd, T. F. 1997. TNFα promotes growth of virulent M. tuberculosis in human monocytes: Iron-mediated growth suppression is correlated with decreased release of TNFα from iron-treated, infected monocytes. J. Clin. Investig. 99:2518-2529.
11. Byrd, T. F., G. M. Green, S. E. Fowlston, and C. R. Lyons. 1998. Differential growth characteristics and streptomycin susceptibility of virulent and avirulent Mycobacterium tuberculosis in a novel fibroblast-mycobacterium microcolony assay. Infect. Immun. 66:5132-5139.
12. Byrd, T. F. 1998. Multinucleated giant cell formation induced by IFNγ/IL-3 is associated with restriction of virulent Mycobacterium tuberculosis cell to cell invasion in human monocyte monolayers. Cell. Immunol. 188:89-96.
13. Cage, G. Personal communication.
14. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257-270.
15. Collins, F. M., and D. S. Cunningham. 1981. Systemic Mycobacterium kansasii infection and regulation of the alloantigenic response. Infect. Immun. 22:614-624.
16. Conville, P. Personal communication.
17. Frehel, C., C. de Chastellier, T. Lang, and N. Rastogi. 1986. Evidence for inhibition of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52:252-262.
18. Griffith, D. E., W. Girard, and R. J. Wallace. 1993. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am. Rev. Respir. Dis. 147:1271-1278.
19. Griffiths, G., G. Warren, T. Quinn, O. Mathieu-Costello, and H. Hoppeler. 1984. Density of newly synthesized plasma membrane proteins in intracellular membranes. I. Stereological studies. J. Cell Biol. 98:2133-2141.
20. Kindler, V., A. Sappino, G. E. Grau, and P. Piguet. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
21. Meylan, P. R. A., D. D. Richman, and R. S. Kornbluth. 1992. Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure. Am. Rev. Respir. Dis. 145:947-953.
22. Middlebrook, G. 1945. Pathogenic components of tubercle bacilli. Am. Rev. Tuberc. 51:244-259.
23. Mills, J. A., M. R. McNeil, J. T. Belisle, W. R. Jacobs, and P. J. Brennan. 1994. Loci of Mycobacterium avium ser2 gene cluster and their functions. J. Bacteriol. 176:4803-4808.
24. Moreira, A. L., J. Wang, L. Tsenova-Berkova, W. Hellmann, V. H. Freedman, and G. Kaplan. 1997. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route. Infect. Immun. 65:305-308.
25. Neill, M., and S. J. Klebanoff. 1988. The effect of phenolic glycolipid-1 from Mycobacterium leprae on antimicrobial activity of human macrophages. J. Exp. Med. 167:30-42.
26. Oh, Y. K., and R. M. Straubinger. 1996. Intracellular fate of Mycobacterium avium: use of dual label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction. Infect. Immun. 64:319-325.
27. Pagan-Ramos, E., J. Song, M. McFalone, M. H. Mudd, and V. Deretic. 1998. Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. J. Bacteriol. 180:4856-4864.
28. Prince, D. S., et al. 1989. Infection with Mycobacterium avium complex in patients without predisposing conditions. New Engl. J. Med. 321:863-868.
29. Ramakrishnan, L., R. H. Valdivia, J. H. McKerrow, and S. Falkow. 1997. Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect. Immun. 65:767-773.
30. Sarmento, A., and R. Appelberg. 1996. Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. Infect. Immun. 64:3224-3230.
31. Schaefer, W. B., C. L. Davis, and M. L. Conn. 1970. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am. Rev. Respir. Dis. 102:499-506.
32. Shinnick, T. M., and R. C. Good. 1994. Mycobacterial taxonomy. Eur. J. Clin. Microbiol. Infect. Dis. 13:884-901.
33. Sommers, H. M., and R. C. Good. 1985. Mycobacterium, p. 225. In E. H. Lennette (ed.), Manual of clinical microbiology, 4th ed. ASM Press, Washington, D.C.
34. Wright, P. W., and R. J. Wallace. 1995. Syndromes, diagnosis and treatment of rapidly growing mycobacteria, p. 373-389. In M. D. Rossman and R. R. MacGregor (ed.), Tuberculosis: clinical management and new challenges. McGraw Hill. Inc., New York, N.Y.